GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Naturland Holding Zrt (BUD:NATURLAND) » Definitions » Loans Receivable

Naturland Holding Zrt (BUD:NATURLAND) Loans Receivable : Ft0 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Naturland Holding Zrt Loans Receivable?

Naturland Holding Zrt's Loans Receivable for the quarter that ended in Jun. 2024 was Ft0 Mil.


Naturland Holding Zrt Loans Receivable Historical Data

The historical data trend for Naturland Holding Zrt's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Naturland Holding Zrt Loans Receivable Chart

Naturland Holding Zrt Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Loans Receivable
- - - -

Naturland Holding Zrt Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Loans Receivable Get a 7-Day Free Trial - - - - -

Naturland Holding Zrt Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


Naturland Holding Zrt Loans Receivable Related Terms

Thank you for viewing the detailed overview of Naturland Holding Zrt's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Naturland Holding Zrt Business Description

Traded in Other Exchanges
N/A
Address
Csillagvirag utca 8, Budapest, HUN, 1106
Naturland Holding Zrt thro9ugh its subsidiaries engage in the production of pharmaceutical products. It engages in the development, production, and wholesale of dietary supplements and cosmetics, herbal medicine, teas, and essential oils. The firm offers tablets, suppositories, ointments, and ophthalmic base solutions.

Naturland Holding Zrt Headlines

No Headlines